The chief executive of Teva Pharmaceuticals says he is making “strong progress” on the company’s restructuring plan, but has acknowledged the generic drug giant faces a challenging 2018.
Kare Schultz, Teva’s new CEO, provides the update as the company releases its fourth-quarter earnings Thursday.
Kåre Schultz, CEO and president of Teva. (Courtesy)
Teva in December announced plans to cut 14,000 jobs, roughly one-quarter of its work force, in a broad restructuring as it confronts lower prices for generics, the expiration of patents on its core Copaxone drug and a more than $30 billion debt load.
Speaking to analysts, Schultz says roughly half the layoffs should be complete by July, with the remainder taking place by the end of 2019. “Everything is on plan. Everything is on target,” he says.
Teva forecasts lower revenue for 2018.
— AP
Help us report truthfully on social media
As a multimedia journalist, my job is to take the quality, fact-based journalism produced by The Times of Israel newsroom and make it accessible across every platform — from Instagram posts to podcasts to short-form videos.
This is how many, especially young people, consume news these days. But misinformation is rampant on social media. Our team at ToI produces accurate, responsible short-form reporting on Israel and the Jewish world.
If you believe in the importance of factual social media journalism, please consider joining our reader support group, The Times of Israel Community. Your financial support is essential to sustain responsible multimedia reporting.
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you, David Horovitz, Founding Editor of The Times of Israel
From the Liveblog of
Thursday, February 8, 2018
Add ToI as a Preferred Source on Google
